NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $394,000 | -55.0% | 8,068 | -2.0% | 0.28% | -58.2% |
Q1 2018 | $875,000 | -16.5% | 8,230 | -53.1% | 0.67% | -17.7% |
Q4 2017 | $1,048,000 | +5.6% | 17,542 | -57.5% | 0.82% | -6.8% |
Q3 2017 | $992,000 | +22.5% | 41,316 | -0.3% | 0.88% | +22.8% |
Q2 2017 | $810,000 | -18.0% | 41,420 | -1.6% | 0.71% | -7.0% |
Q1 2017 | $988,000 | +91.1% | 42,109 | -0.0% | 0.77% | +92.5% |
Q4 2016 | $517,000 | -31.3% | 42,124 | -3.9% | 0.40% | -35.2% |
Q3 2016 | $753,000 | +13.6% | 43,851 | -6.0% | 0.62% | +3.5% |
Q2 2016 | $663,000 | -70.9% | 46,626 | -71.8% | 0.60% | -69.1% |
Q1 2016 | $2,277,000 | -25.2% | 165,584 | -8.3% | 1.92% | -13.0% |
Q4 2015 | $3,043,000 | +47.5% | 180,601 | -4.0% | 2.21% | +50.6% |
Q3 2015 | $2,063,000 | +184.2% | 188,220 | +224.2% | 1.47% | +220.0% |
Q2 2015 | $726,000 | +53.8% | 58,053 | +35.2% | 0.46% | +67.5% |
Q1 2015 | $472,000 | – | 42,938 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |